Cargando…

LOX-1: Regulation, Signaling and Its Role in Atherosclerosis

Atherosclerosis has long been known to be a chronic inflammatory disease. In addition, there is intense oxidative stress in atherosclerosis resulting from an imbalance between the excess reactive oxygen species (ROS) generation and inadequate anti-oxidant defense forces. The excess of the oxidative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kattoor, Ajoe John, Goel, Akshay, Mehta, Jawahar L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680802/ https://www.ncbi.nlm.nih.gov/pubmed/31336709 http://dx.doi.org/10.3390/antiox8070218

Ejemplares similares

LOX-1: Implications in atherosclerosis and myocardial ischemia
por: Sharma, Tanya, et al.
Publicado: (2022)

LOX-1 and Angiotensin Receptors, and Their Interplay
por: Wang, Xianwei, et al.
Publicado: (2011)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence
por: Khaidakov, Magomed, et al.
Publicado: (2011)

Utility of Inferior Lead Q-waveforms in diagnosing Ventricular Tachycardia
por: Subramany, Swathi, et al.
Publicado: (2020)

MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1
por: Dai, Yao, et al.
Publicado: (2018)

LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies
por: Rizzacasa, Barbara, et al.
Publicado: (2017)

Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1expression
por: Ding, Zufeng, et al.
Publicado: (2013)

MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1
por: Dai, Yao, et al.
Publicado: (2016)

A Case of Unintentional Release of the Watchman FLX Device During Implantation: A Cautionary Tale
por: Kattoor, Ajoe J, et al.
Publicado: (2023)

Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE(-/-) mice
por: Yan, Li, et al.
Publicado: (2021)

Intrapericardial Fibrinolytic Therapy in Purulent Pericarditis: A Review of Two Cases
por: Poudyal, Abhushan, et al.
Publicado: (2023)

Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein
por: Thakkar, Shraddha, et al.
Publicado: (2015)

LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension
por: Li, Xiao, et al.
Publicado: (2021)

Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset
por: Di Rienzo, Carmine, et al.
Publicado: (2013)

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
por: Gu, Lei, et al.
Publicado: (2013)

Left-Sided Prosthetic Valve Dysfunction and Gastrointestinal Bleeding
por: Hussain, Kifah, et al.
Publicado: (2023)

Protective Effects of Chinese Traditional Medicine Longhu Rendan against Atherosclerosis via Negative Regulation of LOX-1
por: Yan, Sishan, et al.
Publicado: (2018)

Lysyl Oxidase (LOX): Functional Contributions to Signaling Pathways
por: Laczko, Rozalia, et al.
Publicado: (2020)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease
por: Twigg, M. W, et al.
Publicado: (2012)

Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?
por: Goel, Akshay, et al.
Publicado: (2018)

LOX-1 and cancer: an indissoluble liaison
por: Murdocca, M., et al.
Publicado: (2021)

Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019)

The Discovery of LOX-1, its Ligands and Clinical Significance
por: Yoshimoto, Ryo, et al.
Publicado: (2011)

Ursolic Acid Attenuates Atherosclerosis in ApoE(−/−) Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway
por: Li, Qiu, et al.
Publicado: (2018)

Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
por: Vincent, Andrea M., et al.
Publicado: (2009)

MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo
por: Liu, Mingxin, et al.
Publicado: (2017)

Aerobic Exercise Training Inhibits Neointimal Formation via Reduction of PCSK9 and LOX-1 in Atherosclerosis
por: Li, Wei, et al.
Publicado: (2020)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022)

Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Oxidized LDL and LOX-1 in Experimental Sepsis
por: Al-Banna, Nadia, et al.
Publicado: (2013)

The IL-1 Family and Its Role in Atherosclerosis
por: González, Leticia, et al.
Publicado: (2022)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

LOX-1 in Ischemic Stroke
por: Sawamura, Tatsuya, et al.
Publicado: (2017)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides
por: Hu, Wei, et al.
Publicado: (2017)

Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1
por: Mentrup, Torben, et al.
Publicado: (2021)

LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs
por: Shiraki, Takeru, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ncskghevv1gj90838l6789biet